Breaking News Instant updates and real-time market news.

2020-05-04 10:52:18 ATASY Atlantia $0.00 / + (+0.00%) 10:52 05/04/20 05/04 10:52 05/04/20 10:52	Atlantia price target raised to EUR 17 from EUR 16 at JPMorgan JPMorgan analyst Elodie Rall raised the firm's price target on Atlantia to EUR 17 from EUR 16 and keeps an Overweight rating on the shares. The analyst believes the stock's risk-reward remains attractive.
ATASY Atlantia $0.00 / + (+0.00%) 04/21/20 JPMorgan Atlantia price target lowered to EUR 16 from EUR 17 at JPMorgan 04/02/20 BofA Atlantia upgraded to Buy from Neutral at BofA 03/25/20 Exane BNP Paribas Atlantia downgraded to Neutral from Outperform at Exane BNP Paribas 03/19/20 JPMorgan Atlantia price target lowered to EUR 17 from EUR 25 at JPMorgan

2020-05-04 10:52:18

ATASY

Atlantia

$0.00 / + (+0.00%)

10:52

05/04/20

05/04

10:52

05/04/20

10:52

Atlantia price target raised to EUR 17 from EUR 16 at JPMorgan

JPMorgan analyst Elodie Rall raised the firm's price target on Atlantia to EUR 17 from EUR 16 and keeps an Overweight rating on the shares. The analyst believes the stock's risk-reward remains attractive.

ATASY Atlantia

$0.00 / + (+0.00%)

04/21/20 JPMorgan: Atlantia price target lowered to EUR 16 from EUR 17 at JPMorgan

04/02/20 BofA: Atlantia upgraded to Buy from Neutral at BofA

03/25/20 Exane BNP Paribas: Atlantia downgraded to Neutral from Outperform at Exane BNP Paribas

03/19/20 JPMorgan: Atlantia price target lowered to EUR 17 from EUR 25 at JPMorgan

TODAY'S FREE FLY STORIES

Upgrade	Vaalco Energy upgraded to Buy from Neutral at Roth Capital » 11:44 04/13/21 04/13 11:44 04/13/21 11:44 EGY Vaalco Energy $2.20 / -0.04 (-1.79%) Roth Capital analyst John… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research EGY Vaalco Energy $2.20 / -0.04 (-1.79%) 04/12/21 Vaalco Energy CEO Cary Bounds to leave, George Maxwell to succeed 03/18/21 Vaalco Energy CFO Elizabeth Prochnow to retire 11/17/20 Vaalco Energy to acquire Sasol Gabon interest in Etame Marine block EGY Vaalco Energy $2.20 / -0.04 (-1.79%) 04/12/21 Roth Capital Vaalco Energy downgraded to Neutral from Buy at Roth Capital 03/24/21 Roth Capital Vaalco Energy initiated with a Buy at Roth Capital
Recommendations	Fortuna Silver Mines price target raised to C$12.50 from C$12.25 at BMO Capital » 11:43 04/13/21 04/13 11:43 04/13/21 11:43 FSM Fortuna Silver Mines $7.48 / +0.315 (+4.40%) BMO Capital analyst Ryan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options FSM Fortuna Silver Mines $7.48 / +0.315 (+4.40%) 04/12/21 Fortuna Silver Mines produces 1.9M ounces of silver, 34.555 ounces of gold in Q1 02/01/21 Silver producers up in pre-market on r/wallstreetbets short squeeze speculation 01/28/21 Fortuna Silver Mines rises 20.4% 01/19/21 Fortuna Silver Mines sees FY21 gold production 178,000-202,000 ounces FSM Fortuna Silver Mines $7.48 / +0.315 (+4.40%) 03/29/21 BMO Capital Fortuna Silver Mines price target lowered to $12.75 from $13 at BMO Capital 03/11/21 BMO Capital Fortuna Silver Mines price target raised to C$13 from C$12 at BMO Capital 02/08/21 CIBC Fortuna Silver Mines price target lowered to C$11.25 from C$11.50 at CIBC 02/02/21 National Bank Fortuna Silver Mines price target raised to C$13.50 from C$13 at National Bank FSM Fortuna Silver Mines $7.48 / +0.315 (+4.40%) 03/10/21 Fortuna Silver Mines reports Q4 EPS 10c, consensus 10c 11/13/20 Fortuna Silver Mines reports Q3 EPS 7c, consensus 10c FSM Fortuna Silver Mines $7.48 / +0.315 (+4.40%) 02/01/21 CME raises Silver futures margins by 18% to curb volatility, Bloomberg says FSM Fortuna Silver Mines $7.48 / +0.315 (+4.40%) 02/01/21 Fly Intel: Wall Street's top stories for Monday 02/01/21 Fly Intel: Wall Street's top stories at midday 11/13/20 Fly Intel: Pre-market Movers FSM Fortuna Silver Mines $7.48 / +0.315 (+4.40%) 02/01/21 Fortuna Silver Mines call volume above normal and directionally bullish 02/01/21 Unusually active option classes on open February 1st 01/28/21 Fortuna Silver Mines call volume above normal and directionally bullish 01/21/21 Fortuna Silver Mines call volume above normal and directionally bullish
Conference/Events	Global Ship Lease management to meet virtually with Jefferies » 11:42 04/13/21 04/13 11:42 04/13/21 11:42 GSL Global Ship Lease $12.75 / -0.14 (-1.09%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events GSL Global Ship Lease $12.75 / -0.14 (-1.09%) 04/09/21 Global Ship Lease falls -7.2% 02/09/21 Global Ship Lease to acquire seven Post-Panamax containerships for $116M 01/22/21 Global Ship Lease falls -12.5% 01/22/21 Global Ship Lease falls -12.4% GSL Global Ship Lease $12.75 / -0.14 (-1.09%) 02/12/21 Fly Intel: Top five analyst initiations 02/12/21 Jefferies Global Ship Lease initiated with a Buy at Jefferies 01/15/21 B. Riley Securities Global Ship Lease price target raised to $20 from $16 at B. Riley Securities 01/06/21 B. Riley Securities Global Ship Lease price target raised to $16 from $12 at B. Riley Securities GSL Global Ship Lease $12.75 / -0.14 (-1.09%) 03/04/21 Global Ship Lease reports Q4 revenue $70M, consensus $69.18M 09 Apr 22 Jan GSL Global Ship Lease $12.75 / -0.14 (-1.09%) 04/09/21 Fly Intel: Pre-market Movers 12:00 Today Global Ship Lease
Initiation	Daqo New Energy initiated with a Sell at GLJ Research » 11:39 04/13/21 04/13 11:39 04/13/21 11:39 DQ Daqo New Energy $66.50 / -0.54 (-0.81%) GLJ Research analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options DQ Daqo New Energy $66.50 / -0.54 (-0.81%) 03/16/21 Daqo New Energy enters three-year polysilicon supply agreement with Gaojing 03/09/21 Daqo New Energy rises 22.7% 03/09/21 Daqo New Energy rises 16.2% 03/09/21 Daqo New Energy rises 14.1% DQ Daqo New Energy $66.50 / -0.54 (-0.81%) 03/10/21 Roth Capital Daqo New Energy price target lowered to $97 from $115 at Roth Capital 03/02/21 Roth Capital Daqo New Energy price target raised to $115 from $105 at Roth Capital 02/08/21 Roth Capital Bill could be 'meaningful positive' for solar stocks, says Roth Capital 01/26/21 Roth Capital Daqo New Energy price target raised to $100 from $40 at Roth Capital DQ Daqo New Energy $66.50 / -0.54 (-0.81%) 03/09/21 Daqo New Energy reports Q4 EPS $1.07, one estimate $1.15 DQ Daqo New Energy $66.50 / -0.54 (-0.81%) 01/08/21 JinkoSolar, Daqo named in report on companies tied to forced labor use, NYT says DQ Daqo New Energy $66.50 / -0.54 (-0.81%) 03/09/21 Fly Intel: Pre-market Movers 02/13/21 Charged: Tesla discloses $1.5B bitcoin investment 01/09/21 Charged: Apple self-driving EV said to be years away 12/26/20 Charged: Apple's potential EV entry seen as 'Tesla bear case' 04/22/21 Alternative Energy DQ Daqo New Energy $66.50 / -0.54 (-0.81%) 02/25/21 Daqo New Energy call volume above normal and directionally bullish 01/11/21 Daqo New Energy put volume heavy and directionally bearish
Hot Stocks	MoneyGram announces partnership with Sigue Corporation » 11:34 04/13/21 04/13 11:34 04/13/21 11:34 MGI MoneyGram $6.46 / -0.01 (-0.15%) MoneyGram International… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MGI MoneyGram $6.46 / -0.01 (-0.15%) 04/06/21 MoneyGram appoints Hilary Jackson as COO 03/24/21 MoneyGram announces launch of 'MoneyGram as a Service' business 03/18/21 MoneyGram to join Pay+ mobile wallet, expand in Middle East 03/11/21 MoneyGram's digital business reports 118% y-o-y transaction growth in February MGI MoneyGram $6.46 / -0.01 (-0.15%) 02/25/21 Barclays MoneyGram price target raised to $6 from $4.50 at Barclays 01/19/21 DA Davidson DA Davidson doesn't see Walmart adding Western Union to hurt Euronet materially 01/11/21 Northland MoneyGram upgraded to Outperform from Market Perform at Northland 08/03/20 Evercore ISI MoneyGram upgraded to In Line from Underperform at Evercore ISI MGI MoneyGram $6.46 / -0.01 (-0.15%) 02/22/21 MoneyGram sees Q1 revenue approximately $300M, consensus $298.53M 02/22/21 MoneyGram reports Q4 adjusted EPS 12c, consensus 8c 01/25/21 Fly Intel: What to watch in credit card space earnings reports 10/30/20 MoneyGram sees Q4 revenue growth of 1%, consensus $308.02M MGI MoneyGram $6.46 / -0.01 (-0.15%) 12/21/20 MoneyGram backs stronger due diligence rule, WSJ reports MGI MoneyGram $6.46 / -0.01 (-0.15%) 03/12/21 The Intersection: Crypto and Wall Street This Week 02/22/21 Fly Intel: Wall Street's top stories for Monday 02/22/21 Fly Intel: Wall Street's top stories at midday 02/22/21 Fly Intel: Pre-market Movers 05/05/21 MoneyGram International Inc MGI MoneyGram $6.46 / -0.01 (-0.15%) 12/16/20 MoneyGram call volume above normal and directionally bullish 12/03/20 MoneyGram call volume above normal and directionally bullish 11/20/20 MoneyGram call volume above normal and directionally bullish 11/16/20 MoneyGram call volume above normal and directionally bullish

Recommendations	Novocure price target raised to $215 from $135 at Wells Fargo » 11:34 04/13/21 04/13 11:34 04/13/21 11:34 NVCR Novocure $183.50 / +51.89 (+39.43%) Wells Fargo analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events NVCR Novocure $183.50 / +51.89 (+39.43%) 07:48 Today Zai Lab partner Novocure updates phase 3 Lunar trial in tumor fields in NSCLC 07:40 Today Novocure: DMC recommends continuation of LUNAR trial 12/14/20 Novocure announces BAG to add Optune combination to MiGeL 12/10/20 Novocure enrolls 1st patient in global phase 3 TRIDENT trial NVCR Novocure $183.50 / +51.89 (+39.43%) 10:48 Today Guggenheim Zai Lab price target raised to $250 from $165 at Guggenheim 09:26 Today Piper Sandler DMC review 'clear positive' for Novocure, says Piper Sandler 03/01/21 Mizuho Novocure price target raised to $175 from $150 at Mizuho 02/25/21 Piper Sandler 'Overreaction to downside' in Novocure a buying opportunity, says Piper Sandler NVCR Novocure $183.50 / +51.89 (+39.43%) 02/25/21 Novocure reports Q4 EPS 4c, consensus 12c 01/11/21 Novocure sees FY20 revenue $494.4M, consensus $482.29M 01/11/21 Novocure sees Q4 revenue $144M, consensus $133.26M 10/29/20 Novocure reports Q3 EPS 9c, consensus 3c NVCR Novocure $183.50 / +51.89 (+39.43%) 08:58 Today Fly Intel: Pre-market Movers 04/29/21 Novocure - NVCR
Periodicals	GM shortens expected downtime at Tennessee plant, CNBC reports » 11:28 04/13/21 04/13 11:28 04/13/21 11:28 GM General Motors $58.37 / -1.295 (-2.17%) General Motors is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options GM General Motors $58.37 / -1.295 (-2.17%) 04/12/21 General Motors launches Maps+ in-vehicle navigation solution 04/06/21 GM says Chevrolet will introduce Silverado electric pickup truck 04/05/21 GM to reveal plans for additional EV production at Factory ZERO plant 04/01/21 GM targets recovering lost production where possible in second half GM General Motors $58.37 / -1.295 (-2.17%) 04/05/21 Fly Intel: Top five analyst initiations 04/05/21 Wells Fargo General Motors initiated with an Overweight at Wells Fargo 03/29/21 Jefferies General Motors price target raised to $62 from $50 at Jefferies 03/24/21 Morgan Stanley American Axle downgraded to Underweight on ICE phase out risk at Morgan Stanley GM General Motors $58.37 / -1.295 (-2.17%) 02/10/21 General Motors sees FY21 EBIT-adjusted of $1.5B-$2B 02/10/21 General Motors reports Q4 International EBIT-adjusted of $0.3B 02/10/21 General Motors sees FY21 adjusted EPS $4.50-$5.25, consensus $5.89 02/10/21 General Motors reports Q4 GM North America EBIT-adjusted of $2.6B GM General Motors $58.37 / -1.295 (-2.17%) 04/12/21 Chip shortage meeting not seen producing substantive outcomes, Bloomberg says 04/12/21 General Motors' Cruise to expand self-driving vehicles to Dubai, CNBC reports 04/09/21 GM to cut overtime production at two U.S. truck plants this weekend, CNBC says 04/08/21 GM to pause output at several North American plants amid chip shortage, WSJ says GM General Motors $58.37 / -1.295 (-2.17%) 04/12/21 Charged: White House proposal calling for $100B in new EV consumer rebates 04/06/21 Fly Intel: Wall Street's top stories for Tuesday 04/05/21 Fly Intel: Wall Street's top stories for Monday 04/05/21 Charged: Wedbush says buy Tesla after 'paradigm changer' deliveries GM General Motors $58.37 / -1.295 (-2.17%) 04/07/21 Notable open interest changes for April 7th 03/24/21 General Motors call volume above normal and directionally bullish 03/03/21 Notable open interest changes for March 3rd 03/02/21 General Motors call volume above normal and directionally bullish
Options	iQiyi call volume above normal and directionally bullish » 11:25 04/13/21 04/13 11:25 04/13/21 11:25 IQ iQIYI $16.69 / +0.515 (+3.18%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options IQ iQIYI $16.69 / +0.515 (+3.18%) 03/31/21 Moonbug Entertainment brings CoComelon to China through iQIYI partnership 03/15/21 iQIYI, Clover Films announce collaboration for four upcoming film productions 02/10/21 iQIYI Launches Imax Enhanced in China 02/08/21 Aurora Mobile enters partnership agreement with iQIYI IQ iQIYI $16.69 / +0.515 (+3.18%) 02/22/21 KeyBanc iQIYI upgraded to Overweight from Sector Weight at KeyBanc 02/18/21 Fly Intel: Top five analyst downgrades 02/18/21 JPMorgan iQIYI downgraded to Underweight from Neutral at JPMorgan 01/19/21 UBS iQIYI downgraded to Neutral from Buy at UBS IQ iQIYI $16.69 / +0.515 (+3.18%) 02/17/21 iQIYI sees Q1 revenue $1.08B-$1.15B, consensus $1.13B 02/17/21 iQIYI reports Q4 EPS (32c), consensus (38c) 11/16/20 iQIYI sees Q4 revenue $1.07B-$1.14B, consensus $1.13B 11/16/20 iQIYI reports Q3 EPS (24c), consensus (40c) 17 Dec IQ iQIYI $16.69 / +0.515 (+3.18%) 03/29/21 Former Tiger Asia manager triggered $30B in stock sales, WSJ reports 12/02/20 House approves bill restricting Chinese firms on U.S exchanges, Bloomberg says 11/27/20 Alibaba, Tencent put talks to buy control of iQIYI on hold, Reuters reports 10/13/20 Chinese online video platforms drop Apple iPhone event, Bloomberg's Yuan reports IQ iQIYI $16.69 / +0.515 (+3.18%) 03/29/21 Analysts upgrade ViacomCBS, GSX Techedu as selloff in shares continues 12/16/20 Fly Intel: Pre-market Movers 12/15/20 Fly Intel: After-Hours Movers 11/16/20 Fly Intel: After-Hours Movers IQ iQIYI $16.69 / +0.515 (+3.18%) 04/07/21 Notable open interest changes for April 7th 04/06/21 iQiyi call volume above normal and directionally bullish 04/06/21 Unusually active option classes on open April 6th 03/25/21 iQiyi put volume heavy and directionally bearish
Conference/Events	Cowen Washington strategist to hold analyst/industry conference call » 11:25 04/13/21 04/13 11:25 04/13/21 11:25 Washington Strategist… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Periodicals	KKR planning to outbid CVC for Toshiba with offer in excess of $20B, FT reports » 11:23 04/13/21 04/13 11:23 04/13/21 11:23 TOSYY Toshiba $20.85 / +0.03 (+0.14%) , KKR KKR $52.09 / +0.08 (+0.15%) KKR (KKR) is planning to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events TOSYY KKR TOSYY Toshiba $20.85 / +0.03 (+0.14%) 04/09/21 Toshiba chairperson Osamu Nagayama comments on CVC Capital acquisition proposal 04/06/21 Toshiba confirms acquisition proposal from CVC Capital 03/02/21 Farallon Capital urges Toshiba shareholders to support Farallon EGM proposal KKR KKR $52.09 / +0.08 (+0.15%) 04/08/21 KKR to lead purchase of $500M of convertible preferred stock in Box 04/08/21 Box reaffirms vision to deliver Content Cloud, drive profitable growth 04/08/21 Box announces partnership with KKR, including $500M KKR-led investment 04/08/21 Box announces partnership with KKR, including $500M KKR-led investment TOSYY KKR TOSYY Toshiba $20.85 / +0.03 (+0.14%) 03/19/21 SMBC Nikko Toshiba upgraded to Outperform from Neutral at SMBC Nikko 02/19/21 Citi Toshiba resumed with a Neutral at Citi 04/22/20 UBS Toshiba downgraded to Neutral from Buy at UBS KKR KKR $52.09 / +0.08 (+0.15%) 04/09/21 DA Davidson Box price target lowered to $22 from $25 at DA Davidson 04/09/21 William Blair KKR investment 'strong vote of confidence' in Box, says William Blair 04/09/21 William Blair KKR investment 'strong vote of confidence' in Box, says William Blair 04/07/21 Seaport Global Seaport downgrades Sempra Energy to Neutral after 'good, not great' SIP deal KKR KKR KKR $52.09 / +0.08 (+0.15%) 02/08/21 KKR reports Q4 EPS 49c, consensus 40c 02/08/21 Notable companies reporting after market close 10/30/20 KKR reports Q3 EPS 48c, consensus 40c 11 Nov TOSYY KKR TOSYY Toshiba $20.85 / +0.03 (+0.14%) 04/06/21 CVC to propose taking Toshiba private at 30% premium, Nikkei says 12/29/20 Toshiba holds emergency board meeting amid investor demands, FT reports 12/18/20 Toshiba shareholder escalates dispute with management, FT reports 12/14/20 Toshiba, Fuji Electric to invest $1.9B in EV power chips, Nikkei reports KKR KKR $52.09 / +0.08 (+0.15%) 03/23/21 Thoma Bravo to acquire Calabrio from KKR, no terms, Reuters reports 03/17/21 Fly Leasing receives six bids for aircraft leasing portfolio, AFJ reports 03/11/21 KKR targets $12B for flagship global infrastructure fund, Reuters reports 02/19/21 Apple demands Steam sales data from Valve, PCGamer reports TOSYY KKR TOSYY Toshiba $20.85 / +0.03 (+0.14%) 04/06/21 Fly Intel: Wall Street's top stories for Tuesday KKR KKR $52.09 / +0.08 (+0.15%) 04/08/21 Fly Intel: Wall Street's top stories for Thursday 04/08/21 Fly Intel: Wall Street's top stories at midday 03/09/21 Game On: Microsoft completes Bethesda deal, promises exclusive games 01/12/21 Game On: Roblox files for direct listing as GameStop adds new directors 08:30 Today KKR & Co. Inc.

Recommendations	Stelco Holdings price target raised to C$34 from C$29 at RBC Capital » 11:20 04/13/21 04/13 11:20 04/13/21 11:20 STZHF Stelco Holdings $23.05 / -0.23 (-0.99%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Events STZHF Stelco Holdings $23.05 / -0.23 (-0.99%) 03/31/21 Scotiabank Stelco Holdings price target raised to C$32 from C$30 at Scotiabank 02/24/21 RBC Capital Stelco Holdings upgraded to Outperform from Sector Perform at RBC Capital 02/22/21 Exane BNP Paribas Stelco Holdings upgraded to Outperform from Neutral at Exane BNP Paribas 02/03/21 Credit Suisse Stelco Holdings upgraded to Outperform from Neutral at Credit Suisse 00:00 Today Scrap, Direct Reduced Iron & Mini-Mills 2021
General news	Treasury announced an $80 B set of 4- and 8-week bill auctions for Thursday » 11:20 04/13/21 04/13 11:20 04/13/21 11:20 $ECON Economic Data / + Treasury announced an $80… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><<
Recommendations	Ascot Resources price target lowered to C$1.85 from C$2 at Desjardins » 11:19 04/13/21 04/13 11:19 04/13/21 11:19 AOTVF Ascot Resources / + Desjardins analyst David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research AOTVF Ascot Resources / + 03/18/21 Ascot Resources provides update on permitting, engineering of PGP 11/19/20 Ascot Resources announces high-grade gold intercepts at the Day Zone 10/15/20 Ascot Resources places order for SAG, ball mills AOTVF Ascot Resources / + 12/11/20 Raymond James Ascot Resources price target raised to C$2 from C$1.75 at Raymond James 09/25/20 Raymond James Ascot Resources initiated with a Strong Buy at Raymond James 04/29/20 Roth Capital Roth Capital bullish on Ascot Resources, initiates with a Buy 04/29/20 Roth Capital Ascot Resources initiated with a Buy at Roth Capital
Recommendations	Rigel results in severe COVID-19 trial 'pretty dramatic,' says Piper Sandler » 11:19 04/13/21 04/13 11:19 04/13/21 11:19 RIGL Rigel Pharmaceuticals $3.50 / +0.405 (+13.09%) After Rigel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events RIGL Rigel Pharmaceuticals $3.50 / +0.405 (+13.09%) 07:07 Today Rigel announces results from Phase 2 clinical trial of fostamatinib 04/07/21 Rigel Pharmaceuticals closes R552 licensing agreement with Eli Lilly 03/11/21 Rigel Pharma completes patient enrollment for Phase 2 trial of fostamatinib 02/18/21 Eli Lilly, Rigel Pharmaceuticals enter exclusive license agreement for R552 RIGL Rigel Pharmaceuticals $3.50 / +0.405 (+13.09%) 02/18/21 H.C. Wainwright Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright 02/18/21 Piper Sandler Rigel share setup 'distinctly positive' after Lilly deal, says Piper Sandler 11/09/20 Fly Intel: Top five analyst downgrades 11/09/20 JPMorgan Rigel Pharmaceuticals downgraded to Neutral from Overweight at JPMorgan RIGL Rigel Pharmaceuticals $3.50 / +0.405 (+13.09%) 03/02/21 Rigel Pharmaceuticals reports Q4 EPS (11c), consensus (11c) 01/11/21 Rigel Pharmaceuticals sees Q4 revenue approximately $18.4M, consensus $17.81M 11/05/20 Rigel Pharmaceuticals reports Q3 EPS (8c), consensus (12c) RIGL Rigel Pharmaceuticals $3.50 / +0.405 (+13.09%) 01/15/21 Rigel looks to choke 'storm' that causes Covid patients to die, SFBT says 08:00 Today Rigel Pharmaceuticals - RIGL 05/18/21 Rigel Pharmaceuticals Inc.
Conference/Events	Immunocore participates in a conference call with JPMorgan » 11:19 04/13/21 04/13 11:19 04/13/21 11:19 IMCR Immunocore $34.25 / +2.03 (+6.30%) SMid Cap Biotech Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events IMCR Immunocore $34.25 / +2.03 (+6.30%) 03/25/21 Immunocore expects cash to fund requirement through at least the end of 2022 02/19/21 Immunocore's tebentafusp granted Breakthrough Therapy Designation IMCR Immunocore $34.25 / +2.03 (+6.30%) 03/02/21 Jefferies Immunocore initiated with a Buy at Jefferies 03/02/21 JPMorgan Immunocore initiated with an Overweight at JPMorgan 03/02/21 Goldman Sachs Immunocore initiated with a Neutral at Goldman Sachs IMCR Immunocore $34.25 / +2.03 (+6.30%) 03/25/21 Immunocore reports 2020 EPS (GBP2.79) vs. (GBP4.66) last year 05 Feb IMCR Immunocore $34.25 / +2.03 (+6.30%) 02/07/21 Opening Day: Sana raises largest-ever IPO for preclinical biotech 07:30 Today Immunocore - IMCR 04/14/21 Immunocore - IMCR

Technical Analysis	NASDAQ market internals summary » 11:17 04/13/21 04/13 11:17 04/13/21 11:17 $NSD NASDAQ Market Internals / + Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals / + 10:17 Today NASDAQ market internals summary 04/12/21 NASDAQ market internals summary 04/12/21 NASDAQ market internals summary 04/12/21 NASDAQ market internals summary
Conference/Events	Akero Therapeutics participates in a conference call with JPMorgan » 11:16 04/13/21 04/13 11:16 04/13/21 11:16 AKRO Akero Therapeutics $26.88 / -0.29 (-1.07%) SMid Cap Biotech Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events AKRO Akero Therapeutics $26.88 / -0.29 (-1.07%) 03/23/21 Akero says1st patient randomized for dosing in EFX study in F2/F3 NASH patients 03/22/21 Akero Therapeutics histological improvements in cirrhotic NASH post cohort C 11/13/20 Akero announces presentation of additional BALANCED study data analysis 10/16/20 Akero Therapeutics receives EMA PRIME designation for efruxifermin in NASH AKRO Akero Therapeutics $26.88 / -0.29 (-1.07%) 03/23/21 H.C. Wainwright Akero Therapeutics price target raised to $68 from $61 at H.C. Wainwright 03/23/21 Chardan Akero NASH data 'very exciting outcome,' says Chardan 03/17/21 Chardan Akero Therapeutics price target raised to $81 from $79 at Chardan 02/26/21 Guggenheim Akero Therapeutics initiated with a Buy at Guggenheim AKRO Akero Therapeutics $26.88 / -0.29 (-1.07%) 03/16/21 Akero Therapeutics reports Q4 EPS (86c), consensus (59c) 11/12/20 Akero Therapeutics reports Q3 EPS (63c), consensus (65c) 08 Jul AKRO Akero Therapeutics $26.88 / -0.29 (-1.07%) 03/16/21 Fly Intel: Pre-market Movers 13:00 Today Akero Therapeutics - AKRO
Technical Analysis	NYSE market internals summary » 11:16 04/13/21 04/13 11:16 04/13/21 11:16 $NYE NYSE Market Internals / + Volume is average for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals / + 10:16 Today NYSE market internals summary 04/12/21 NYSE market internals summary 04/12/21 NYSE market internals summary 04/12/21 NYSE market internals summary
Recommendations	Western Forest price target raised to C$2.50 from C$1.90 at CIBC » 11:15 04/13/21 04/13 11:15 04/13/21 11:15 WFSTF Western Forest $1.59 / -0.0029 (-0.18%) CIBC analyst Hamir Patel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research WFSTF Western Forest $1.59 / -0.0029 (-0.18%) 03/03/21 Scotiabank Western Forest price target raised to C$2.25 from C$2 at Scotiabank 02/22/21 RBC Capital Western Forest price target raised to C$2 from C$1.50 at RBC Capital 02/22/21 TD Securities Western Forest price target raised to C$2 from C$1.75 at TD Securities 02/19/21 Scotiabank Western Forest price target raised to C$2 from C$1.50 at Scotiabank
Recommendations	West Fraser Timber price target raised to C$135 from C$120 at CIBC » 11:15 04/13/21 04/13 11:15 04/13/21 11:15 WFG West Fraser Timber $82.77 / +0.95 (+1.16%) CIBC analyst Hamir Patel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research WFG West Fraser Timber $82.77 / +0.95 (+1.16%) 04/07/21 Scotiabank West Fraser Timber price target raised to C$120 from C$106 at Scotiabank 03/26/21 TD Securities West Fraser Timber upgraded to Action List Buy from Buy at TD Securities 03/03/21 Scotiabank West Fraser Timber price target raised to C$106 from C$103 at Scotiabank 02/16/21 TD Securities West Fraser Timber price target raised to $91 from $86 at TD Securities

Options	Charles Schwab put volume heavy and directionally bearish » 11:15 04/13/21 04/13 11:15 04/13/21 11:15 SCHW Charles Schwab $67.09 / -0.63 (-0.93%) Bearish flow noted in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SCHW Charles Schwab $67.09 / -0.63 (-0.93%) 01/29/21 Charles Schwab says trading not restricted in GameStop, others 12/21/20 Charles Schwab unit fined GBP8.96M by U.K.'s Financial Conduct Authority 11/13/20 Charles Schwab reports October core new assets of $25.6B 10/29/20 Charles Schwab CFO says near-term accretion math 'better' for TD Ameritrade deal SCHW Charles Schwab $67.09 / -0.63 (-0.93%) 04/09/21 Fly Intel: Top five analyst upgrades 04/09/21 Jefferies Charles Schwab price target raised to $76 from $70 at Jefferies 04/09/21 JPMorgan Charles Schwab price target raised to $81 from $79 at JPMorgan 04/09/21 Deutsche Bank Charles Schwab price target raised to $79 from $77 at Deutsche Bank SCHW Charles Schwab $67.09 / -0.63 (-0.93%) 01/19/21 Charles Schwab reports Q4 adjusted EPS 74c, consensus 71c 10/15/20 Charles Schwab reports Q3 adj. EPS 51c, consensus 46c 10/14/20 Notable companies reporting before tomorrow's open 10/14/20 Notable companies reporting before tomorrow's open SCHW Charles Schwab $67.09 / -0.63 (-0.93%) 03/04/21 Charles Schwab considering launching crypto brokerage, The Block reports 02/10/21 Charles Schwab cuts 200 workers amid TD Ameritrade integration, Bloomberg says 11/17/20 Trading platform Robinhood may go public next year, Bloomberg reports 10/15/20 Robinhood says almost 2,000 brokerage accounts hacked, Bloomberg reports SCHW Charles Schwab $67.09 / -0.63 (-0.93%) 03/05/21 The Intersection: Crypto and Wall Street This Week 03/04/21 Fly Intel: Wall Street's top stories for Thursday 02/01/21 Square Cash App seen emerging as biggest winner from 'Robinhood drama' 10/15/20 Fly Intel: Pre-market Movers 05/13/21 Charles Schwab Corp. SCHW Charles Schwab $67.09 / -0.63 (-0.93%) 03/29/21 Charles Schwab put volume heavy and directionally bearish 02/10/21 Charles Schwab put volume heavy and directionally bearish 02/03/21 Charles Schwab put volume heavy and directionally bearish 01/28/21 Charles Schwab put volume heavy and directionally bearish
Recommendations	Toromont Industries price target raised to C$100 from C$95 at CIBC » 11:14 04/13/21 04/13 11:14 04/13/21 11:14 TMTNF Toromont Industries $77.45 / -0.33 (-0.42%) CIBC analyst Jacob Bout… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TMTNF Toromont Industries $77.45 / -0.33 (-0.42%) 04/06/21 Scotiabank Toromont Industries price target raised to C$115 from C$100 at Scotiabank 04/06/21 Scotiabank Scotiabank upgrades Toromont to Outperform, says premium valuation warranted 04/05/21 Scotiabank Toromont Industries upgraded to Outperform from Sector Perform at Scotiabank 02/16/21 TD Securities Toromont Industries price target raised to C$98 from C$95 at TD Securities
On The Fly	Johnson & Johnson under pressure as FDA calls for pause on COVID vaccine » 11:12 04/13/21 04/13 11:12 04/13/21 11:12 JNJ Johnson & Johnson $157.42 / -4.165 (-2.58%) , MRNA Moderna $150.11 / +10.82 (+7.77%) , PFE Pfizer $37.14 / +0.16 (+0.43%) Shares of Johnson &… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options JNJ MRNA PFE JNJ Johnson & Johnson $157.42 / -4.165 (-2.58%) 09:47 Today White House says J&J pause will not significantly impact vaccination plan 09:25 Today Johnson & Johnson to 'proactively delay' rollout of vaccine in Europe 07:53 Today Moderna up 7% to $149.10 after CDC, FDA recommend pause in J&J vaccine use 07:15 Today J&J drops 3% to $156.50 after CDC, FDA recommend pause in vaccine use MRNA Moderna $150.11 / +10.82 (+7.77%) 09:47 Today White House says J&J pause will not significantly impact vaccination plan 09:28 Today Moderna says available mRNA-1273 data doesn't suggest association with CVST 07:53 Today Moderna up 7% to $149.10 after CDC, FDA recommend pause in J&J vaccine use 04/07/21 Moderna says NEJM study shows COVID antibody persistence out to 6 months PFE Pfizer $37.14 / +0.16 (+0.43%) 09:47 Today White House says J&J pause will not significantly impact vaccination plan 07:53 Today Moderna up 7% to $149.10 after CDC, FDA recommend pause in J&J vaccine use 04/12/21 AgroFresh Solutions appoints Clinton Lewis Jr. as CEO 04/12/21 Myovant Sciences, Pfizer: First patient dosed in Phase 3 SERENE study JNJ MRNA PFE JNJ Johnson & Johnson $157.42 / -4.165 (-2.58%) 09:34 Today Goldman Sachs J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs 09:33 Today Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 09:21 Today JPMorgan Vaccine pause 'incremental negative' for J&J, says JPMorgan 08:15 Today Piper Sandler Piper reiterates $208 target on Moderna after J&J Covid vaccine pause MRNA Moderna $150.11 / +10.82 (+7.77%) 09:33 Today Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 08:15 Today Piper Sandler Piper reiterates $208 target on Moderna after J&J Covid vaccine pause 04/07/21 Jefferies Catalent pact with Moderna removes potential overhang, says Jefferies 03/15/21 Piper Sandler Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study PFE Pfizer $37.14 / +0.16 (+0.43%) 09:33 Today Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 09:21 Today JPMorgan Vaccine pause 'incremental negative' for J&J, says JPMorgan 04/09/21 Pfizer to host conference call 04/06/21 RBC Capital Pfizer transferred with a Sector Perform at RBC Capital JNJ MRNA PFE JNJ Johnson & Johnson $157.42 / -4.165 (-2.58%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open MRNA Moderna $150.11 / +10.82 (+7.77%) 02/25/21 Moderna reports Q4 EPS (69c), consensus (35c) 02/24/21 Notable companies reporting before tomorrow's open 02/24/21 Notable companies reporting before tomorrow's open 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) PFE Pfizer $37.14 / +0.16 (+0.43%) 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer reports Q4 adjusted EPS 42c, consensus 48c 02/01/21 Notable companies reporting before tomorrow's open 19 May JNJ MRNA PFE JNJ Johnson & Johnson $157.42 / -4.165 (-2.58%) 09:48 Today NY replacing Tuesday's J&J vaccine appointments with Pfizer, Axios reports 09:48 Today CVS Health tells Bloomberg pausing administration of J&J COVID vaccine 07:00 Today U.S. to call for pause on J&J vaccine after blood clotting cases, NYT reports 04/09/21 J&J in talks for trial in India of COVID-19 vaccine, Business Standard says MRNA Moderna $150.11 / +10.82 (+7.77%) 04/06/21 U.K. to initiate Moderna vaccine rollout Wednesday, Bloomberg says 04/06/21 Biden to say all U.S. adults should be vaccine-eligible by April 19, WSJ says 04/06/21 Catalent to nearly double Moderna vaccine output at Indiana plant, WSJ reports 03/26/21 White House weighs lifting IP protections for COVID-19 vaccines, CNBC says PFE Pfizer $37.14 / +0.16 (+0.43%) 09:48 Today NY replacing Tuesday's J&J vaccine appointments with Pfizer, Axios reports 04/12/21 Study shows Covid variant may evade protection from Pfizer vaccine, Reuters says 04/09/21 EU seeks contract for 1.8B COVID-19 doses with Pfizer, BioNTech, Reuters reports 04/06/21 Biden to say all U.S. adults should be vaccine-eligible by April 19, WSJ says JNJ MRNA PFE JNJ Johnson & Johnson $157.42 / -4.165 (-2.58%) 08:58 Today Fly Intel: Pre-market Movers 04/09/21 Fly Intel: Wall Street's top stories for Friday 04/09/21 Fly Intel: Wall Street's top stories at midday 04/05/21 Fly Intel: Wall Street's top stories for Monday MRNA Moderna $150.11 / +10.82 (+7.77%) 08:58 Today Fly Intel: Pre-market Movers 04/06/21 Fly Intel: Wall Street's top stories for Tuesday 04/06/21 Fly Intel: Wall Street's top stories at midday 03/29/21 Fly Intel: Wall Street's top stories for Monday PFE Pfizer $37.14 / +0.16 (+0.43%) 04/10/21 Opening Day: Phone maker UTime soars in public debut 04/09/21 Fly Intel: Wall Street's top stories for Friday 04/05/21 Fly Intel: Wall Street's top stories for Monday 04/01/21 Fly Intel: Wall Street's top stories for Thursday 04/20/21 Johnson & Johnson - JNJ 05/04/21 Pfizer - PFE 05/07/21 Moderna - MRNA 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 04/14/21 Moderna 04/22/21 Pfizer Inc 04/22/21 Johnson & Johnson 04/28/21 Moderna, Inc. JNJ MRNA PFE JNJ Johnson & Johnson $157.42 / -4.165 (-2.58%) 09:40 Today Unusually active option classes on open April 13th 04/01/21 Unusually active option classes on open April 1st 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th MRNA Moderna $150.11 / +10.82 (+7.77%) 10:25 Today Moderna call volume above normal and directionally bullish 03/17/21 Moderna call volume above normal and directionally bullish 03/01/21 Moderna call volume above normal and directionally bullish 02/01/21 Moderna call volume above normal and directionally bullish PFE Pfizer $37.14 / +0.16 (+0.43%) 04/12/21 Unusually active option classes on open April 12th 04/09/21 Pfizer call volume above normal and directionally bullish 04/09/21 Early notable gainers among liquid option names on April 9th 03/15/21 Pfizer call volume above normal and directionally bullish
Conference/Events	JPMorgan biotech/pharma analysts hold an analyst/industry conference call » 11:10 04/13/21 04/13 11:10 04/13/21 11:10 Biotechnology Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Recommendations	Stella-Jones price target raised to C$60 from C$57 at CIBC » 11:10 04/13/21 04/13 11:10 04/13/21 11:10 STLJF Stella-Jones $41.00 / + (+0.00%) CIBC analyst Hamir Patel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research STLJF Stella-Jones $41.00 / + (+0.00%) 03/12/21 Desjardins Stella-Jones price target raised to C$61 from C$55 at Desjardins 03/11/21 CIBC Stella-Jones price target raised to C$57 from C$54 at CIBC 03/11/21 RBC Capital Stella-Jones price target raised to C$55 from C$53 at RBC Capital 03/11/21 TD Securities Stella-Jones price target raised to C$59 from C$56 at TD Securities

Events

Earnings calls, analyst events, roadshows and more

HA
Today at 12:00

Hawaiian Airlines Executives Deliver Speech Government Event

Virtual Event
Today at 12:00

Fed Reserve Bank President Speaks on Economic Conditions Government Event

Virtual Event
Today at 12:00

Fed Reserve Bank President Delivers Opening Remarks Government Event

Virtual Event
GSL
Today at 12:00

Global Ship Lease Firm Sponsored Meetings

Virtual Meeting
Today at 12:00

Washington Research Policy Industry Meetings
Today at 12:00

Biotech/Pharma Industry Meetings
Today at 13:00

30-Year Bond Auction Government Event
AKRO
Today at 13:00

Akero Therapeutics - AKRO Conference Calls
Today at 13:15

Fed Reserve Bank President Moderates Virtual Panel Government Event

Virtual Event
BKSC
Today at 14:00

Bank of South Carolina Corp Firm Sponsored Meetings

256 Meeting St, Charleston, SC

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CHWY X CHWY Chewy Block Trade Managers: Morgan Stanley Priced at: $82.50 6.1M Shares EPRT X EPRT Essential Properties Realty Trust Spot Secondary Managers: Citi, BofA & Barclays Priced at: $23.50 7.15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GFL X GFL GFL Environmental Spot Secondary Managers: BMO Capital, RBC Capital & Scotiabank Priced at: $33.95 17.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	ALKT X ALKT Alkami IPO Managers: Goldman Sachs, JPMorgan & Barclays, Citi, William Blair, JMP Securities, KeyBanc, Needham $26.00-28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	COIN X COIN Coinbase Direct Listing Managers: Direct Listing $ 114.851M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AGL X AGL Agilon Health IPO Managers: JPMorgan, Goldman Sachs & BofA, Deutsche Bank, Wells Fargo, William Blair, Truist, Nomura $20.00-23.00 46.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APP X APP AppLovin IPO Managers: Morgan Stanley, JPMorgan, KKR, BofA & Citi, Credit Suisse, UBS, Oppenheimer, Stifel, Truist, William Blair, Truist, Luma, Guzman & Company, LionTree Advisors, The Raine Group, Blaylock Van, R. Seelaus $75.00-85.00 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRT X KRT Karat Packaging IPO Managers: Stifel, William Blair & Truist, National Securities, DA Davidson $18.00-20.00 3.95M Shares TSP X TSP TuSimple IPO Managers: Morgan Stanley, Citi & JPMorgan, BofA, Cowen, Credit Suisse, Nomura, RBC Capital, Baird, Needham, Oppenheimer, Piper Sandler, Valuable Capital $35.00-39.00 33.784M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	AKYA X AKYA Akoya Biosciences IPO Managers: JPMorgan, Morgan Stanley, Piper Sandler & Canaccord $18.00-20.00 6.58M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BMEA X BMEA Biomea Fusion IPO Managers: JPMorgan, Jefferies & Piper Sandler $15.00-17.00 7.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RXRX X RXRX Recursion Pharmaceuticals IPO Managers: Goldman Sachs & JPMorgan, BofA, SVB Leerink, Allen & Co., KeyBanc $16.00-18.00 18M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BALY X BALY Bally's Secondary Managers: Deutsche Bank, Goldman Sachs & Barclays $60.80 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Atlantia price target raised to EUR 17 from EUR 16 at JPMorgan

TODAY'S FREE FLY STORIES

Get Full Fly Access